Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Using Zinc Oxide Versus Moist Exposed Wound Ointment (MEBO) in Treatment of Second Stage Pressure Ulcer: A Randomized Control Clinical Trial

NCT07193849 is registered in ClinicalTrials.gov with King Abdullah Medical City as lead sponsor.

NCT NCT07193849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07193849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Using Zinc Oxide Versus Moist Exposed Wound Ointment (MEBO) in Treatment of Second Stage Pressure Ulcer: A Randomized Control Clinical Trial
Lead sponsor
King Abdullah Medical City
Phase
Phase 4
Overall status
Recruiting
Start date
December 31, 2023
Completion date
December 31, 2025
Enrollment
76 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bedsore, pressure injury, pressure injury stage 2, pressure ulcer, buttock, pressure ulcers stage ii